Linked Life Data

10919162

Source:http://linkedlifedata.com/resource/pubmed/id/10919162

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2000-8-15
pubmed:abstractText
The detection of TSH-receptor-antibodies (TRAb) in patients (pts) with Graves' disease (GD) is routinely used in nuclear medicine laboratories. It is performed by commercial, porcine radioreceptorassays (RRA) measuring TSH binding inhibitory activity. A second generation assay using the human, recombinant TSH-receptor was developed during the last years. The manufacturer composed this new assay as a coated tube RRA (CT RRA) and claimed a higher sensitivity for GD.
pubmed:language
ger
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0029-5566
pubmed:author
pubmed:issnType
Print
pubmed:volume
39
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
113-20
pubmed:dateRevised
2007-1-12
pubmed:meshHeading
pubmed:year
2000
pubmed:articleTitle
[Measurement of thyrotropin receptor antibodies (TRAK) with a second generation assay in patients with Graves' disease].
pubmed:affiliation
Klinik und Poliklinik für Nuklearmedizin, Universitätsklinikum Carl Gustav Carus, Technischen Universität Dresden, Deutschland. kzophel@rcs.urz.tu-dresden.de
pubmed:publicationType
Journal Article, Comparative Study, English Abstract